Age and space irradiation modulate tumor progression: Implications for carcinogenesis risk

Radiation Research

Volumn 179, Issue 2, 2013, Pages 208-220

  Beheshti, Afshin ^a   Sachs, Rainer K ^a,b   Peluso, Michael ^a   Rietman, Edward ^a   Hahnfeldt, Philip ^a   Hlatky, Lynn ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; IRON;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; COSMONAUT; ENERGY; GENE EXPRESSION; HUMAN; HUMAN CELL; IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

AGING; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; EXTRATERRESTRIAL ENVIRONMENT; IRON; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, RADIATION-INDUCED; PROTEIN INTERACTION MAPS; RISK; TRANSCRIPTOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84874050784     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR3100.1     Document Type: Article

References (74)

1. Weinberg RA. The biology of cancer. 1st ed. New York: Garland Science; 2007.
2. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER cancer statistics review, 1975-2005 http:// seer.cancer.gov/csr/1975- 2005/, based on November 2007 SEER data submission. 1st ed. Bethesda, MD: National Cancer Institute; 2008.
3. Izumi S, Ohtaki M. Incorporation of inter-individual heterogeneity into the multistage carcinogenesis model: approach to the analysis of cancer incidence data. Biom J 2007; 49:539-50.
4. Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ. A new view of radiation-induced cancer: integrating short-and long-term processes. Part I: approach. Radiat Environ Biophys 2009; 48:263-74.
5. Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res 1999; 59:4770-5.
6. Deisboeck TS, Wang Z. Cancer dissemination: A consequence of limited carrying capacity? Med Hypotheses 2007; 69:173-7.
7. Moolgavkar SH, Luebeck EG. Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer 2003; 38:302-6.
8. Anisimov VN, Sikora E, Pawelec G. Relationships between cancer and aging: A multilevel approach. Biogerontology 2009; 10:323-8.
9. Kreisle RA, Stebler BA, Ershler WB. Effect of host age on tumorassociated angiogenesis in mice. J Natl Cancer Inst 1990; 82:44-7.
10. Lewis DA, Travers JB, Spandau DF. A new paradigm for the role of aging in the development of skin cancer. J Invest Dermatol 2009; 129:787-91.
11. Bojovic B, Crowe DL. Chronologic aging decreases tumor angiogenesis and metastasis in a mouse model of head and neck cancer. Int J Oncol 2010; 36:715-23.
12. Reed MJ, Karres N, Eyman D, Cruz A, Brekken RA, Plymate S. The effects of aging on tumor growth and angiogenesis are tumorcell dependent. Int J Cancer 2007; 120:753-60.
13. Bryl E, Witkowski JM. Decreased proliferative capability of CD4() cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T cells. Exp Gerontol 2004; 39:587-95.
14. Duan W, Gao L, Wu X, Hade EM, Gao JX, Ding H, et al. Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice. PLoS One 2009; 4:e5563.
15. Hinkal G, Parikh N, Donehower LA. Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression. PLoS One 2009; 4:e6654.
16. Gatza C, Moore L, Dumble M, Donehower LA. Tumor suppressor dosage regulates stem cell dynamics during aging. Cell Cycle 2007; 6:52-5.
17. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell 2008; 132:681-96.
18. Morton CI, Hlatky L, Hahnfeldt P, Enderling H. Non-stem cancer cell kinetics modulate solid tumor progression. Theor Biol Med Model 2012; 8:48.
19. Thijssen DH, Vos JB, Verseyden C, van Zonneveld AJ, Smits P, Sweep FC, et al. Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 2006; 5:495-503.
20. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109:1801-9.
21. Cucinotta FA, Durante M. Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. Lancet Oncol 2006; 7:431-5.
22. Held KD. Effects of low fluences of radiations found in space on cellular systems. Int J Radiat Biol 2009; 85:379-90.
23. Cucinotta FA, Schimmerling W, Wilson JW, Peterson LE, Badhwar GD, Saganti PB, et al. Space radiation cancer risks and uncertainties for Mars missions. Radiat Res 2001; 156:682-8.
24. Weil MM, Bedford JS, Bielefeldt-Ohmann H, Ray FA, Genik PC, Ehrhart EJ, et al. Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon (56)Fe ions. Radiat Res 2009; 172:213-9.
25. Alpen EL, Powers-Risius P, Curtis SB, DeGuzman R, Fry RJ. Fluence-based relative biological effectiveness for charged particle carcinogenesis in mouse Harderian gland. Adv Space Res 1994; 14:573-81.
26. Peng Y, Borak TB, Bouffler SD, Ullrich RL, Weil MM, Bedford JS. Radiation leukemogenesis in mice: loss of PU.1 on chromosome 2 in CBA and C57BL/6 mice after irradiation with 1 GeV/nucleon 56Fe ions, X rays or gamma Rays. Part II. Theoretical considerations based on microdosimetry and the initial induction of chromosome aberrations. Radiat Res 2009; 171:484-93
27. Autsavapromporn N, De Toledo SM, Buonanno M, Jay-Gerin JP, Harris AL, Azzam EI. Intercellular communication amplifies stressful effects in high-charge, high-energy (HZE) particleirradiated human cells. J Radiat Res 2011; 52:408-14.
28. Mao XW, Favre CJ, Fike JR, Kubinova L, Anderson E, Campbell-Beachler M, et al. High-LET radiation-induced response of microvessels in the Hippocampus. Radiat Res 2010; 173:486-93.
29. Durante M, Cucinotta FA. Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer 2008; 8:465-72.
30. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7:763-77
31. Gonzalez E, McGraw TE. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 2009; 8:2502-8.
32. Mishra P, Banerjee D, Ben-Baruch A. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 2011; 89:31-9.
33. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010; 16:2927-31.
34. Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, et al. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer Metas Rev 2010; 29:709-22.
35. Bertram JS, Janik P. Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer Lett 1980; 11:63-73
36. Kunstyr I, Leuenberger HG. Gerontological data of C57BL/6J mice. I. Sex differences in survival curves. J Gerontol 1975; 30:157-62.
37. Carnes BA, Grahn D, Hoel D. Mortality of atomic bomb survivors predicted from laboratory animals. Radiat Res 2003; 160:159-67.
38. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-8.
39. Askenazi M, Li S, Singh S, Marto JA. Pathway palette: A rich internet application for peptide-, protein-and network-oriented analysis of MS data. Proteomics 2010; 10:1880-5.
40. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007; 2:2366-82.
41. Sprenger CC, Plymate SR, Reed MJ. Extracellular influences on tumour angiogenesis in the aged host. Br J Cancer 2008; 98:250-5.
42. Wagatsuma A. Effect of aging on expression of angiogenesisrelated factors in mouse skeletal muscle. Exp Gerontol 2006; 41:49-54.
43. Zhong C, Fleming N, Lu X, Moore P, Liu H. Age-associated differences in gene expression in response to delayed anesthetic preconditioning. Age 2011.
44. Flavin R, Zadra G, Loda M. Metabolic alterations and targeted therapies in prostate cancer. J Pathol 2011; 223:283-94.
45. Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 2009; 100:1369-72.
46. Tang J, Enderling H, Becker-Weimann S, Pham C, Polyzos A, Chen CY, et al. Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling. Integr Biol 2011; 3:408-21.
47. Dillon RL, Muller WJ. Distinct biological roles for the akt family in mammary tumor progression. Cancer Res 2011; 70:4260-4.
48. Lee MW, Kim DS, Lee JH, Lee BS, Lee SH, Jung HL, et al. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration. Cancer Sci 2011.
49. Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 2006; 66:32-48.
50. Kim K, Kim HY, Cho HK, Kim KH, Cheong J. The SDF-1alpha/ CXCR4 axis induces the expression of fatty acid synthase via sterol regulatory element-binding protein-1 activation in cancer cells. Carcinogenesis 2010; 31:679-86.
51. Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/ CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007; 50:274-80.
52. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: A molecular hub modulating neo-angiogenesis. Trends Immunol 2007; 28:299-307.
53. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007; 292:C987-95.
54. Sun YX, Schneider A, Jung Y, Wang J, Dai J, Cook K, et al. Skeletal localization and neutralization of the SDF-1(CXCL12)/ CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 2005; 20:318-29.
55. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121:335-48
56. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, et al. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 2005; 65:5864-71.
57. Ma M, Ye JY, Deng R, Dee CM, Chan GC. Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling. Cancer Lett 2011; 312:1-10.
58. Rhodes LV, Antoon JW, Muir SE, Elliott S, Beckman BS, Burow ME. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/ CXCR4 crosstalk. Mol Cancer 2010; 9:295.
59. Lerman OZ, Greives MR, Singh SP, Thanik VD, Chang CC, Seiser N, et al. Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and-independent SDF-1 induction. Blood 2010; 116:3669-7660.
60. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000; 106:1331-9.
61. Jung MJ, Rho, JK, Kim YM, Jung JE, Jim YB, Ko YG, et al. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells. Oncogene 2012.
62. Pierce DA, Vaeth M. Age-time distribution of cancer risks to be expected from acute or chronic exposures to general mutagens. Radiat Res 2000; 154:727-8.
63. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22.
64. Wang HQ, Altomare DA, Skele KL, Poulikakos PI, Kuhajda FP, Di Cristofano A, et al. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 2005; 24:3574-82.
65. Jackowski S. Coordination of membrane phospholipid synthesis with the cell cycle. J Biol Chem 1994; 269:3858-67.
66. Menendez JA, Lupu R, Colomer R. Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. Drug News Perspect 2005; 18:375-85.
67. Jain MR, Li M, Chen W, Liu T, de Toledo SM, Pandey BN, et al. In vivo space radiation-induced non-targeted responses: late effects on molecular signaling in mitochondria. Curr Mol Pharmacol 2011; 4:106-14
68. Yin F, Boveris A, Cadenas E. Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal 2012.
69. Cerqueira FM, Kowaltowski AJ. Mitochondrial metabolism in aging: Effect of dietary interventions. Ageing Res Rev 2012.
70. Bratic I, Trifunovic A. Mitochondrial energy metabolism and ageing. Biochim Biophys Acta 2010; 1797(6-7):961-7.
71. Page MM, Robb EL, Salway KD, Stuart JA. Mitochondrial redox metabolism: aging, longevity and dietary effects. Mech Ageing Dev 2010; 131(4):242-52.
72. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005; 24:7455-64.
73. Chen ML, Xu PZ, Peng XD, Chen WS, Guzman G, Yang X, et al. The deficiency of Akt1 is sufficient to suppress tumor development in Pten/-mice. Genes Dev 2006; 20:1569-74.
74. Wysoczynski M, Reca R, Ratajczak J, Kucia M, Shirvaikar N, Honczarenko M, et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/ progenitor cells to an SDF-1 gradient. Blood 2005; 105:40-8.